Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) agreed to renew its trademark license agreement with the Shandong Xinhua Pharmaceutical Branch of Hualu Holdings for the full year 2025, a Tuesday Hong Kong bourse filing said.
The company has been using the trademark Xinhua and as it still plans to do so in the future, it agreed to renew the license agreement with the other party.
Under the renewed agreement, the company will pay 10 million yuan in annual license fee to the other party for the exclusive right to use the Trademark.